The October Pharmacy Times Community issue covers clinical topics for pharmacists, from GLP-1 safety questions to everyday medication management.
Recap by typeshit. Post by Facebook on Facebook.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
An NIH study is recruiting to see if an investigational weight loss medication reduces alcohol use and improves liver health.
The law firm explains what Lilly's retatrutide suits mean for pharmacies, telehealth companies and online sellers, as the drug maker goes after unapproved versions.
Loading…